UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 429

Sortiert nach

Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA

Clinical cancer research, 2016-12, Vol.22 (23), p.5772-5782

2016

Volltextzugriff (PDF)

Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma

Autophagy, 2014-08, Vol.10 (8), p.1369-1379

2014

Volltextzugriff (PDF)

Combined MTOR and autophagy inhibition: Phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma

Autophagy, 2014-08, Vol.10 (8), p.1391-1402

2014

Volltextzugriff (PDF)

EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes

Journal of clinical oncology, 2019-02, Vol.37 (4), p.278-285

2019

Volltextzugriff (PDF)

Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2017-04, Vol.106, p.1-7

2017

Volltextzugriff (PDF)

SELECT: A Phase II Trial of Adjuvant Erlotinib in Patients With Resected Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer

Journal of clinical oncology, 2019-01, Vol.37 (2), p.97-104

2019

Volltextzugriff (PDF)

First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring Somatic EGFR Mutations

Journal of clinical oncology, 2008-05, Vol.26 (15), p.2442-2448

2008

Volltextzugriff (PDF)

Cytoplasmic DAXX drives SQSTM1/p62 phase condensation to activate Nrf2-mediated stress response

Nature communications, 2019-08, Vol.10 (1), p.3759-18, Article 3759

2019

Volltextzugriff (PDF)

Prospective study of proton‐beam radiation therapy for limited‐stage small cell lung cancer

Cancer, 2017-11, Vol.123 (21), p.4244-4251

2017

Volltextzugriff (PDF)

Discrepancies of assessments in a RECIST 1.1 phase II clinical trial - association between adjudication rate and variability in images and tumors selection

Cancer imaging, 2018-12, Vol.18 (1), p.50-50, Article 50

2018

Volltextzugriff (PDF)

Palliative Care in Lung Cancer: When to Start

Current oncology reports, 2018-11, Vol.20 (11), p.90-7, Article 90

2018

Volltextzugriff (PDF)

Phase I Study of Intrapleural Gene-Mediated Cytotoxic Immunotherapy in Patients with Malignant Pleural Effusion

Molecular therapy, 2018-05, Vol.26 (5), p.1198-1205

2018

Volltextzugriff (PDF)

Peripheral immune cell gene expression predicts survival of patients with non-small cell lung cancer

PloS one, 2012-03, Vol.7 (3), p.e34392-e34392

2012

Volltextzugriff (PDF)

Cabazitaxel Versus Topotecan in Patients with Small-Cell Lung Cancer with Progressive Disease During or After First-Line Platinum-Based Chemotherapy

Journal of thoracic oncology, 2015-08, Vol.10 (8), p.1221-1228

2015

Volltextzugriff (PDF)

Phase II Trial of Combination Nab-paclitaxel and Gemcitabine in Non–squamous Non–small Cell Lung Cancer After Progression on Platinum and Pemetrexed

Clinical lung cancer, 2022-06, Vol.23 (4), p.e310-e316

2022

Volltextzugriff (PDF)

Impact of Simultaneous Circulating Tumor DNA and Tissue Genotyping in the Workup of Stage IV Lung Adenocarcinoma on Quality of Care in an Academic Community Medical Center

JCO oncology practice, 2023-08, Vol.19 (8), p.620-625

2023

Volltextzugriff (PDF)

A Phase I Trial of the HIV Protease Inhibitor Nelfinavir with Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer: A Report of Toxicities and Clinical Response

Journal of thoracic oncology, 2012-04, Vol.7 (4), p.709-715

2012

Volltextzugriff (PDF)

Brachial Plexopathy in Apical Non-Small Cell Lung Cancer Treated With Definitive Radiation: Dosimetric Analysis and Clinical Implications

International journal of radiation oncology, biology, physics, 2013, Vol.85 (1), p.175-181

2013

Volltextzugriff (PDF)

Legal and regulatory responses to innovative treatment

Medical law review, 2013-12, Vol.21 (1), p.92-130

Chan, Tracey Evans

2013

Volltextzugriff (PDF)

Randomized, double-blind, placebo-controlled, multicenter phase II study of the efficacy and safety of apricoxib in combination with either docetaxel or pemetrexed in patients with biomarker-selected non-small-cell lung cancer

Journal of clinical oncology, 2015-01, Vol.33 (2), p.189-194

2015

Volltextzugriff (PDF)

Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes

Radiotherapy and oncology, 2010-05, Vol.95 (2), p.178-184

2010

Volltextzugriff (PDF)

Etirinotecan Pegol (NKTR-102) in Third-line Treatment of Patients With Metastatic or Recurrent Non–Small-cell Lung Cancer: Results of a Phase II Study

Clinical lung cancer, 2018-03, Vol.19 (2), p.157-162

2018

Volltextzugriff (PDF)

Brief Report: Long-Term Follow-Up of Adjuvant Pembrolizumab After Locally Ablative Therapy for Oligometastatic NSCLC

JTO clinical and research reports, 2024-06, Vol.5 (6), p.100667, Article 100667

2024

Volltextzugriff (PDF)

1 – 25 von 429

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(347)
Mit Volltextzugriff
(388)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Detection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNA

Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma

Combined MTOR and autophagy inhibition: Phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma

EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes

Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer

SELECT: A Phase II Trial of Adjuvant Erlotinib in Patients With Resected Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer

First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring Somatic EGFR Mutations

Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer

Cytoplasmic DAXX drives SQSTM1/p62 phase condensation to activate Nrf2-mediated stress response

Prospective study of proton‐beam radiation therapy for limited‐stage small cell lung cancer

Discrepancies of assessments in a RECIST 1.1 phase II clinical trial - association between adjudication rate and variability in images and tumors selection

Palliative Care in Lung Cancer: When to Start

Phase I Study of Intrapleural Gene-Mediated Cytotoxic Immunotherapy in Patients with Malignant Pleural Effusion

Peripheral immune cell gene expression predicts survival of patients with non-small cell lung cancer

PREdiction and Diagnosis using Imaging and Clinical biomarkers Trial in Traumatic Brain Injury (PREDICT-TBI) study protocol: an observational, prospective, multicentre cohort study for the prediction of outcome in moderate-to-severe TBI

Cabazitaxel Versus Topotecan in Patients with Small-Cell Lung Cancer with Progressive Disease During or After First-Line Platinum-Based Chemotherapy

Phase II Trial of Combination Nab-paclitaxel and Gemcitabine in Non–squamous Non–small Cell Lung Cancer After Progression on Platinum and Pemetrexed

Impact of Simultaneous Circulating Tumor DNA and Tissue Genotyping in the Workup of Stage IV Lung Adenocarcinoma on Quality of Care in an Academic Community Medical Center

A Phase I Trial of the HIV Protease Inhibitor Nelfinavir with Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer: A Report of Toxicities and Clinical Response

Brachial Plexopathy in Apical Non-Small Cell Lung Cancer Treated With Definitive Radiation: Dosimetric Analysis and Clinical Implications

Legal and regulatory responses to innovative treatment

Randomized, double-blind, placebo-controlled, multicenter phase II study of the efficacy and safety of apricoxib in combination with either docetaxel or pemetrexed in patients with biomarker-selected non-small-cell lung cancer

Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes

Etirinotecan Pegol (NKTR-102) in Third-line Treatment of Patients With Metastatic or Recurrent Non–Small-cell Lung Cancer: Results of a Phase II Study

Brief Report: Long-Term Follow-Up of Adjuvant Pembrolizumab After Locally Ablative Therapy for Oligometastatic NSCLC

Suchergebnisse filtern